The Venture Codex

Participated · Seed · Jul 2026

EVERSION develops a corrective insole system built around sensor insoles and an app that collects two weeks of movement data to create a 3D biomechanical model for a custom "0°-sole" insole. The bottom of the insole adjusts load based on user data while the top allows natural foot movement, with the company positioning the product to address misalignment-related knee, hip, and back pain. Founded in 2022 in Konstanz, the team includes founders with backgrounds in orthopaedic shoemaking, engineering, computer science, and sports science. EVERSION achieved CE medical device certification, launched its product, secured reimbursement from German statutory health insurers through a prevention-course program, and has attracted more than 1,500 customers. The company aims to expand its sales channels and partnerships with medical professionals and orthopaedic retailers as it scales.

Participated · Seed · Jun 2026

Maple Aviation develops unmanned aerial vehicle technology to transport medication and laboratory samples between hospitals and laboratories. Founded in 2022 and based in Ottobrunn, Germany, the company is building a medical cargo drone network focused on time-sensitive healthcare deliveries. It plans to move into commercial deployment and scale its logistics network to offer faster, more efficient transfers of medical supplies. Financially, Maple Aviation recently closed a €4 million seed round from a syndicate of investors and also received grant funding from the Regierung von Oberbayern and the European Space Agency. The company’s immediate use of funds is to accelerate rollout and operational readiness of its healthcare-focused drone services.

Participated · Equity · Nov 2025

Memi Textiles GmbH, founded in 2022, is a German startup that creates sustainable textile innovations designed to substitute disposable products containing chemical superabsorbers with reusable, high-performance fabrics. Its core technology weaves multiple high-tech fibers into a proprietary knitted structure that delivers exceptional absorbency for baby diapers, feminine hygiene and incontinence items. Production follows a zero-waste approach, offering significant environmental benefits by reducing landfill waste. In March 2024 the founders introduced their own cloth-diaper brand "kniti," and rising B2B demand—especially from incontinence product makers—has broadened the firm’s market reach. Media visibility increased after the company appeared on the TV show "Die Höhle der Löwen" in September 2025, although a televised deal subsequently collapsed. The freshly secured capital will fund technology scale-up, expanded manufacturing capacity and new hygiene applications. No revenue or user metrics were disclosed, but the company has now raised roughly €700,000 in external funding from a mix of institutional backers and angel investors.

Participated · Series A · Jun 2023

NVision Imaging develops MRI polarizers and hyperpolarized imaging agents that enable metabolic MRI. Its NVision Polarizer uses a parahydrogen-induced polarization (PHIP) technique, applying advances in quantum physics, chemistry, and engineering to deliver fast, robust, and easy-to-use polarization in the MRI setting. The technology aims to detect early metabolic changes at the cellular level, potentially revealing treatment response within days rather than months. NVision planned preclinical use in 2023 and intends to deploy systems for human care in the coming years, targeting installations at over 50 leading cancer centers by 2025. The company has a partnership with Siemens Healthineers and a signed collaboration with Memorial Sloan Kettering to support clinical deployment. Financially, NVision closed a $30M Series A and secured additional government funding to support its clinical advancement.